Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drew Weissman

Showing results (251-260 of 293) with videos related to

Pageof 30
Sort By:
Science Immunology|May 8, 2026
In vivo reprogramming of cytotoxic effector CD8 T cells via fractalkine-conjugated mRNA-LNPsAngela R Corrigan, Shin Foong Ngiow, Maura Statzu, et al.
Immunity|May 1, 2020
The Transcription Factor T-bet Resolves Memory B Cell Subsets with Distinct Tissue Distributions and Antibody Specificities in Mice and HumansJohn L Johnson, Rebecca L Rosenthal, James J Knox, et al.
Cell Host & Microbe|December 11, 2020
D614G Spike Mutation Increases SARS CoV-2 Susceptibility to NeutralizationDrew Weissman, Mohamad-Gabriel Alameh, Thushan de Silva, et al.
ACS Nano|July 11, 2023
Targeted Nanocarriers Co-Opting Pulmonary Intravascular Leukocytes for Drug Delivery to the Injured BrainJia Nong, Patrick M Glassman, Jacob W Myerson, et al.
Biorxiv : the Preprint Server for Biology|January 5, 2021
Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primatesKevin O Saunders, Norbert Pardi, Robert Parks, et al.
Scientific Reports|January 29, 2024
Phase II prefusion non-stabilised Covid-19 mRNA vaccine randomised studyThanyawee Puthanakit, Eakachai Prompetchara, Sivaporn Gatechompol, et al.
Nature Nanotechnology|October 1, 2024
Combinatorial design of siloxane-incorporated lipid nanoparticles augments intracellular processing for tissue-specific mRNA therapeutic deliveryLulu Xue, Gan Zhao, Ningqiang Gong, et al.
Blood|July 1, 2024
Use of HSC-targeted LNP to generate a mouse model of lethal α-thalassemia and treatment via lentiviral gene therapyMaxwell E Chappell, Laura Breda, Lucas Tricoli, et al.
ACS Nano|July 17, 2023
Ionizable Lipid Nanoparticles for Therapeutic Base Editing of Congenital Brain DiseaseRohan Palanki, Sourav K Bose, Apeksha Dave, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 30, 2024
In utero delivery of targeted ionizable lipid nanoparticles facilitates in vivo gene editing of hematopoietic stem cellsRohan Palanki, John S Riley, Sourav K Bose, et al.
Pageof 30

Showing results (251-260 of 293) with videos related to

Sort By:
Pageof 30
Science Immunology|May 8, 2026
In vivo reprogramming of cytotoxic effector CD8 T cells via fractalkine-conjugated mRNA-LNPsAngela R Corrigan, Shin Foong Ngiow, Maura Statzu, et al.
Immunity|May 1, 2020
The Transcription Factor T-bet Resolves Memory B Cell Subsets with Distinct Tissue Distributions and Antibody Specificities in Mice and HumansJohn L Johnson, Rebecca L Rosenthal, James J Knox, et al.
Cell Host & Microbe|December 11, 2020
D614G Spike Mutation Increases SARS CoV-2 Susceptibility to NeutralizationDrew Weissman, Mohamad-Gabriel Alameh, Thushan de Silva, et al.
ACS Nano|July 11, 2023
Targeted Nanocarriers Co-Opting Pulmonary Intravascular Leukocytes for Drug Delivery to the Injured BrainJia Nong, Patrick M Glassman, Jacob W Myerson, et al.
Biorxiv : the Preprint Server for Biology|January 5, 2021
Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primatesKevin O Saunders, Norbert Pardi, Robert Parks, et al.
Scientific Reports|January 29, 2024
Phase II prefusion non-stabilised Covid-19 mRNA vaccine randomised studyThanyawee Puthanakit, Eakachai Prompetchara, Sivaporn Gatechompol, et al.
Nature Nanotechnology|October 1, 2024
Combinatorial design of siloxane-incorporated lipid nanoparticles augments intracellular processing for tissue-specific mRNA therapeutic deliveryLulu Xue, Gan Zhao, Ningqiang Gong, et al.
Blood|July 1, 2024
Use of HSC-targeted LNP to generate a mouse model of lethal α-thalassemia and treatment via lentiviral gene therapyMaxwell E Chappell, Laura Breda, Lucas Tricoli, et al.
ACS Nano|July 17, 2023
Ionizable Lipid Nanoparticles for Therapeutic Base Editing of Congenital Brain DiseaseRohan Palanki, Sourav K Bose, Apeksha Dave, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 30, 2024
In utero delivery of targeted ionizable lipid nanoparticles facilitates in vivo gene editing of hematopoietic stem cellsRohan Palanki, John S Riley, Sourav K Bose, et al.
Pageof 30